分子胶:解锁癌症新靶点
Molecular glues: Unlocking new targets in cancer
瑞典卡罗林斯卡学院和意大利维罗纳大学的研究人员在《Molecular Cell》上发表综述,指出分子胶降解剂通过重新编程细胞自身的降解机制,能够消除疾病相关蛋白,特别是那些难以成药的靶点。该领域目前主要依赖少数几种E3连接酶,未来有望通过识别更多未被利用的E3连接酶,开发出新一代抗癌药物。
The human genome encodes several hundred E3 ligases—the enzymes that decide which proteins a cell destroys. Drug developers have so far harnessed a small number of them. In a new review in Molecular Cell, researchers at Karolinska Institutet and the University of Verona argue that the rest of these E3 ligases are where the next generation of cancer drugs will be found.
Molecular glue degraders are small molecules that rewire the cell's own degradation machinery to eliminate disease-causing proteins, including ones long considered beyond the reach of drugs. They induce proximity between an E3 ligase and a target protein, marking it for destruction. It is one of the fastest-moving areas in drug discovery today.
"The field has so far relied on only a handful of E3 ligases," says Andrä Brunner, co-first author of the review. "We map the molecular mechanisms underlying targeted protein degradation and describe how hidden degrons can be exposed and exploited by the many ligases that remain unused. Expanding this repertoire could open new avenues for reaching challenging targets, particularly in hard-to-treat cancers."
"Knowledge of the interaction interfaces induced by molecular glues that enable an E3 ligase to engage its target is still limited, except for a few well-characterized ligases," say Daniele Guardavaccaro and Angela Lauriola of the University of Verona. "Consequently, the field has thus far relied on only a small number of ligases for drug discovery and development."
The review also sets out the framework for a collaboration between the two groups.
"Much of what we describe as untapped is exactly what we are now focusing on. We are working to identify the E3 ligases that could form the basis of the next generation of targeted protein degraders," says Olle Sangfelt at the Department of Cell and Molecular Biology, Karolinska Institutet.
Publication details
Andrä Brunner et al., Beneath the surface: Hidden degrons and untapped ligases for molecular glue degrader discovery, Molecular Cell (2026). DOI: 10.1016/j.molcel.2026.10.028
Journal information: Molecular Cell
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Molecular glues: Unlocking new targets in cancer (2026, November 20) retrieved 20 November 2026 from https://medicalxpress.com/news/2026-11-molecular-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com